|
Post by gamblerjag on Aug 24, 2016 10:56:07 GMT -5
people bitch just to bitch... damn if they do damn if they don't scenario............ and one never knows if the person has shares or not.. could be a long in disguise.. If I were Matt and Matt I would block goof balls too.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 24, 2016 11:44:22 GMT -5
Interesting buy.
On one hand I think why would they buy if they have to dilute and then on the other are they buying to help price to dilute. Seems like shorts are growing and market not phased by the purchases.
Would SNY payment fall under material information?
|
|
|
Post by sweedee79 on Aug 24, 2016 11:47:35 GMT -5
IMHO, ragging on Matt on proboards is counter-productive to seeing MNKD succeed as a company and improving the public perception. There is complaint if these guys get a big salary, rather than tie their income to performance (incentive). Then there is complaint if they do get options (incentive rather than reward at this price ....) Then complaint if they don't buy stock. Then when they do buy stock, complaint again about the options. Personally, I'm glad they have some stock incentive, but more importantly, are actually buying now. And its nice that they timed some buying with minor tax-selling from the others to more than balance it out. I wish I could like this comment a hundred times, Matt could have given up... he has not!!!!! With all of the BS that has gone on with this company in the past 2 years we are lucky we are still alive.. and that is in large part due to Matt... It is obvious to me that the man cares about the company, but most importantly he cared about Al Mann and the vision he had, he also believes in Afrezza. We need to focus on all of the positive things that have happened in the past few months... I have no doubt about the integrity of the MNKD team.. regardless of mistakes that have been made they are giving it all they've got to put this right and see Afrezza succeed.. the choices they have made in the past few months have been spot on... I am optimistic.. I have no idea why Matt hasn't bought more shares.. that isn't my business.. he has proven enough to me ..
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 24, 2016 11:51:35 GMT -5
Why would he give up. He is filthy rich if he gets the share price up to 2-3 bucks
|
|
|
Post by sweedee79 on Aug 24, 2016 11:55:18 GMT -5
Why would he give up. He is filthy rich if he gets the share price up to 2-3 bucks good grief.. not everyone is a cheat and liar..
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 24, 2016 11:59:32 GMT -5
You sound so foolish. If he gets the stock price up due to his hardwork he can cash in on his options. What does that have to do with being a liar or a cheat.
He makes 700k a year. It's peanuts for a ceo. His wealth are in his options.
|
|
|
Post by tayl5 on Aug 24, 2016 12:00:22 GMT -5
Well, I just bought more. I figure if Mike C had serious concerns about the progress of MannKind 2.0, he could have easily skipped buying stock now. I'm also thinking about the Epi-Pen pricing outrage and the progress MannKind is making toward an inhalable alternative. This is still a great story stock. All we need is some commercial traction to make it fly.
|
|
|
Post by madog365 on Aug 24, 2016 12:03:13 GMT -5
No other way to spin it but positively.
When your chief in charge of product sales is accumulating stock in the open market (3 times!) it shows tremendous confidence.
|
|
|
Post by sweedee79 on Aug 24, 2016 12:08:16 GMT -5
You sound so foolish. If he gets the stock price up due to his hardwork he can cash in on his options. What does that have to do with being a liar or a cheat. He makes 700k a year. It's peanuts for a ceo. His wealth are in his options. I thought we were discussing why Matt hasn't bought more shares... I am simply defending what I see as integrity.. You seem to be saying he has none and is simply out for himself.. what I see is a man who has more into this and it isn't just about the money.. if that is foolish... then I guess I am..
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 24, 2016 12:37:31 GMT -5
You sound so foolish. If he gets the stock price up due to his hardwork he can cash in on his options. What does that have to do with being a liar or a cheat. He makes 700k a year. It's peanuts for a ceo. His wealth are in his options. I thought we were discussing why Matt hasn't bought more shares... I am simply defending what I see as integrity.. You seem to be saying he has none and is simply out for himself.. what I see is a man who has more into this and it isn't just about the money.. if that is foolish... then I guess I am.. I said no such thing. I said why would he give up? We all work for money, that is the point of working. If he improves people's quality of life and becomes filthy rich then he killed two birds with one step while remaining ethical. Not many can say they are able to do both. Leave the emotion at the door.
|
|
|
Post by mnholdem on Aug 24, 2016 12:55:02 GMT -5
Interesting buy. On one hand I think why would they buy if they have to dilute and then on the other are they buying to help price to dilute. Seems like shorts are growing and market not phased by the purchases. Would SNY payment fall under material information? Yes it would, which is probably why management disclosed that information about additional Sanofi payments. Pfeffer, Castagna and other company officers can legally buy MNKD shares based on their belief that:
1. Afrezza sales will increase; 2. Additional Sanofi payments are forthcoming; 3. RLS milestone payment is forthcoming.
...because they have publicly disclosed that information, including additional information such as Direct-to-Patient marketing launching of Afrezza beginning in a few weeks.
|
|
|
Post by mnkdorbust on Aug 24, 2016 12:57:23 GMT -5
Didn't need any more shares but cost averaged down again today. #ImWithMike
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 24, 2016 15:09:36 GMT -5
Interesting buy. On one hand I think why would they buy if they have to dilute and then on the other are they buying to help price to dilute. Seems like shorts are growing and market not phased by the purchases. Would SNY payment fall under material information? Yes it would, which is probably why management disclosed that information about additional Sanofi payments. Pfeffer, Castagna and other company officers can legally buy MNKD shares based on their belief that:
1. Afrezza sales will increase; 2. Additional Sanofi payments are forthcoming; 3. RLS milestone payment is forthcoming.
...because they have publicly disclosed that information, including additional information such as Direct-to-Patient marketing launching of Afrezza beginning in a few weeks.
When did they disclose that? I am on vacation but had gotten an alert because of today's price action.
|
|
|
Post by gamblerjag on Aug 24, 2016 15:19:06 GMT -5
Will also be eom. (paid once a month).. the selfish side hopes for mid 80's the next week.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 24, 2016 18:36:46 GMT -5
He adds 15k more at .87
|
|